Literature DB >> 19118846

Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice.

Toru Kakizaki1, Mitsutomo Kohno, Masazumi Watanabe, Atsushi Tajima, Yotaro Izumi, Taku Miyasho, Sadatomo Tasaka, Koichi Fukunaga, Ikuro Maruyama, Akitoshi Ishizaka, Koichi Kobayashi.   

Abstract

BACKGROUND: Lung resection after induction chemotherapy and/or radiotherapy for down-staging of locally advanced lung cancer can be complicated with lethal interstitial pneumonia. We studied the effects of pneumonectomy on bleomycin-induced lung injury and fibrosis in mice.
METHODS: The mice underwent left pneumonectomy or a sham thoracotomy after intratracheal administration of saline or bleomycin. Lung permeability index, wet-to-dry weight ratio, histological changes, collagen contents, and concentrations of inflammatory mediators and cell counts in broncho-alveolar lavage (BAL) fluid were assessed in the residual right lung 7 d after surgery.
RESULTS: The index of capillary permeability, lung water content, and inflammatory cell counts in BAL fluid were significantly increased by pneumonectomy. These measurements were highest in the mice with both pneumonectomy and intratracheal administration of bleomycin. Similarly, fibrotic change in lung pathology, as well as an increase in lung collagen content, was most prominent in the mice exposed to both interventions. The BAL fluid concentrations of interleukin-1beta, interleukin-6, RANTES, and high mobility group box 1 were significantly increased by pneumonectomy and enhanced by the additional administration of bleomycin.
CONCLUSIONS: The results of this study indicate that pneumonectomy alone causes noncritical lung injury, which amplifies the inflammatory response to bleomycin and promotes lung fibrosis. Several inflammatory mediators appear to be involved in the exacerbation of bleomycin-induced lung injury and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19118846     DOI: 10.1016/j.jss.2008.06.021

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs.

Authors:  Danny Jonigk; Marlene Merk; Kais Hussein; Lavinia Maegel; Katharina Theophile; Michaela Muth; Ulrich Lehmann; Clemens L Bockmeyer; Michael Mengel; Jens Gottlieb; Tobias Welte; Axel Haverich; Heiko Golpon; Hans Kreipe; Florian Laenger
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Alveolar macrophage dynamics in murine lung regeneration.

Authors:  Kenji Chamoto; Barry C Gibney; Maximilian Ackermann; Grace S Lee; Miao Lin; Moritz A Konerding; Akira Tsuda; Steven J Mentzer
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

3.  Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.

Authors:  S Segawa; D Goto; Y Yoshiga; M Sugihara; T Hayashi; Y Chino; I Matsumoto; S Ito; T Sumida
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

4.  Immediate effects of systemic administration of normal and high O2-affinity haemoglobin vesicles as a transfusion alternative in a rat pneumonectomy model.

Authors:  Ryo Hashimoto; Mitsutomo Kohno; Kana Oiwa; Hiroto Onozawa; Masazumi Watanabe; Hirohisa Horinouchi; Hiromi Sakai; Koichi Kobayashi; Masayuki Iwazaki
Journal:  BMJ Open Respir Res       Date:  2020-06

5.  KD025 Shifts Pulmonary Endothelial Cell Bioenergetics and Decreases Baseline Lung Permeability.

Authors:  Ji Young Lee; Reece P Stevens; Mary Kash; Chun Zhou; Anna Koloteva; Phoibe Renema; Sunita S Paudel; Troy Stevens
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.